Q3 2026 13F · SEC CIK 1845943

Thrive Capital Management, LLC

Hedge fundFiled 2026-10-28 for Q3 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $557.4M
Reported positions: 180
Top holdings a year, 3 yrs: +14.3%
Assets under management: $50.5B

Thrive Capital Management, LLC is a hedge fund that reported 180 positions worth $557.4M in its Q3 2026 13F, filed 2026-10-28. Its largest holdings were Invesco Qqq Tr (QQQ, 5.1%), Vanguard Index Fds (VTV, 3.3%), Vanguard Index Fds (VOO, 3.2%). A portfolio copying its top holdings returned 14.3% a year over the last 3 years, against 20.4% for the S&P 500.

Thrive Capital Management, LLC holdings largest 50 of 180 positions.

Weights are shares of the filer's total reported 13F value, compared with Q2 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Thrive Capital Management, LLC 13F holdings
Stock	% of 13F value	Q2 2026	Shares	Share change	Reported value
QQQInvesco Qqq Tr	5.1%	5.4%	38,514	-1.5%	$28.5M
VTVVanguard Index Fds	3.3%	2.6%	83,930	+32.7%	$18.1M
VOOVanguard Index Fds	3.2%	2.7%	25,658	+21.8%	$18.0M
VEAVanguard Ftse Developed Markets Index Fu	3.1%	3.0%	247,216	+11.7%	$17.5M
VUGVanguard Index Fds	2.5%	2.8%	157,541	-9.4%	$14.2M
VOEVanguard Index Fds	2.4%	1.7%	67,010	+43.6%	$13.1M
VBRVanguard Index Fds	2.1%	1.9%	51,875	+25.9%	$12.0M
VWOVanguard Intl Equity Index F	2.0%	2.3%	184,469	-11.3%	$10.9M
VBKVanguard Index Fds	1.9%	2.5%	31,210	-12.2%	$10.5M
QYLDGlobal X Fds	1.7%	1.8%	522,270	+1.7%	$9.7M
AMDAdvanced Micro Devices Inc	1.6%	1.4%	14,700	+15.4%	$9.0M
NVDANvidia Corporation	1.5%	1.3%	37,710	+9.3%	$8.6M
RYLDGlobal X Fds	1.4%	1.5%	520,887	+3.0%	$8.1M
XYLDGlobal X Fds	1.4%	1.4%	190,310	+2.4%	$7.9M
MSFTMicrosoft Corp	1.3%	0.9%	13,582	+0.8%	$7.0M
VNQVanguard Index Fds	1.2%	1.1%	77,084	+31.3%	$6.9M
METAMeta Platforms Inc	1.2%	0.9%	9,262	+13.8%	$6.7M
JNJJohnson & Johnson	1.2%	1.3%	24,345	-7.9%	$6.4M
MUMicron Technology Inc	1.2%	1.1%	6,028	+19.4%	$6.4M
YYYAmplify ETF Tr	1.1%	1.2%	594,722	+5.7%	$6.2M
AAPLApple Inc	1.1%	0.9%	18,222	+15.1%	$6.1M
GOOGLAlphabet Inc	1.0%	1.0%	16,837	+18.7%	$5.8M
JEPIJ P Morgan Exchange Traded F	1.0%	0.9%	97,719	+13.6%	$5.5M
AVGOBroadcom Inc	1.0%	0.9%	15,451	+24.1%	$5.4M
LLYEli Lilly & Co	0.9%	1.0%	4,462	+2.4%	$5.2M
FTNTFortinet Inc	0.9%	—	28,049	—	$5.0M
MPWRMonolithic Pwr Sys Inc	0.9%	—	3,686	—	$5.0M
EXELExelixis Inc	0.9%	0.9%	84,602	-3.5%	$4.9M
FLEXFlex Ltd Ord	0.9%	1.0%	44,707	+43.0%	$4.9M
IGLDFirst Tr Exchange-Traded Fd	0.9%	0.9%	241,657	+4.7%	$4.9M
PGProcter & Gamble Co	0.9%	0.9%	33,552	-0.3%	$4.9M
UTHRUnited Therapeutics Corp Del	0.9%	—	8,956	—	$4.9M
MOAltria Group Inc	0.9%	0.9%	71,270	+2.7%	$4.8M
VVisa Inc	0.9%	0.9%	13,334	-6.3%	$4.8M
GILDGilead Sciences Inc	0.9%	—	32,023	—	$4.8M
RLRalph Lauren Corp	0.9%	0.9%	13,382	+14.6%	$4.8M
HALOHalozyme Therapeutics Inc	0.9%	0.9%	42,988	-32.2%	$4.7M
UHSUniversal Hlth Svcs Inc	0.8%	—	26,733	—	$4.7M
ACNAccenture PLC Ireland	0.8%	—	25,132	—	$4.6M
AVYAvery Dennison Corp	0.8%	0.9%	26,798	-5.2%	$4.6M
VZVerizon Communications Inc	0.8%	—	99,517	—	$4.6M
THCTenet Healthcare Corp	0.8%	0.9%	17,789	-30.7%	$4.5M
CMECme Group Inc	0.8%	—	17,187	—	$4.5M
TROWPrice T Rowe Group Inc	0.8%	0.9%	42,917	-0.6%	$4.5M
MCKMckesson Corp	0.8%	—	5,175	—	$4.4M
PGRProgressive Corp	0.8%	0.9%	21,312	-5.0%	$4.4M
AOSSmith A O Corp	0.8%	0.9%	78,355	-0.6%	$4.4M
CLColgate Palmolive Co	0.8%	0.9%	51,594	+0.7%	$4.4M
ZMZoom Communications Inc	0.8%	—	48,455	—	$4.4M
SNASnap on Inc	0.8%	0.9%	12,054	-0.0%	$4.4M

What Thrive Capital Management, LLC bought and sold in Q3 2026, against Q2 2026.

New positions

Q2 2026's filing was too long to tell new positions apart.

Added to

Reduced

HALO Halozyme Therapeutics Inc-32.2% shares
THC Tenet Healthcare Corp-30.7% shares
VBK Vanguard Index Fds-12.2% shares
VWO Vanguard Intl Equity Index F-11.3% shares
VUG Vanguard Index Fds-9.4% shares
JNJ Johnson & Johnson-7.9% shares
V Visa Inc-6.3% shares
AVY Avery Dennison Corp-5.2% shares

Left the top 50

Share counts compared with the Q2 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +20.0% /yr; S&P 500 +20.1%
3 years: +14.3% /yr; S&P 500 +20.4%
5 years: +5.9% /yr; S&P 500 +11.2%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q3 2026	$557.4M	180
Q2 2026	$530.5M	170
Q1 2026	$456.3M	169
Q4 2025	$449.0M	174
Q3 2025	$387.7M	171
Q2 2025	$319.3M	169
Q1 2025	$167.4M	114
Q4 2024	$218.2M	96
Q3 2024	$212.3M	177
Q2 2024	$218.8M	179
Q1 2024	$187.7M	120
Q4 2023	$186.9M	156

Questions about Thrive Capital Management, LLC's portfolio

What stocks does Thrive Capital Management, LLC own?

Thrive Capital Management, LLC's latest 13F, for Q3 2026 and filed Oct 28, 2026, lists 180 positions worth $557.4M. The largest are Invesco Qqq Tr (QQQ) at 5.1%, Vanguard Index Fds (VTV) at 3.3%, Vanguard Index Fds (VOO) at 3.2%, Vanguard Ftse Developed Markets Index Fu (VEA) at 3.1% and Vanguard Index Fds (VUG) at 2.5%.

What did Thrive Capital Management, LLC buy last quarter?

In Q3 2026, Thrive Capital Management, LLC added Vanguard Index Fds (VOE) (+43.6% shares), Flex Ltd Ord (FLEX) (+43.0% shares) and Vanguard Index Fds (VTV) (+32.7% shares), compared with its Q2 2026 filing.

What did Thrive Capital Management, LLC sell last quarter?

In Q3 2026, Thrive Capital Management, LLC cut from its top 50 Merck & Co Inc (MRK), cut from its top 50 Kimberly-Clark Corp (KMB), cut from its top 50 Illinois Tool Wks Inc (ITW), cut from its top 50 Merit Med Sys Inc (MMSI), cut from its top 50 Neurocrine Biosciences Inc (NBIX), Halozyme Therapeutics Inc (HALO) (-32.2% shares), Tenet Healthcare Corp (THC) (-30.7% shares) and Vanguard Index Fds (VBK) (-12.2% shares), compared with its Q2 2026 filing.

How has Thrive Capital Management, LLC's portfolio performed?

A portfolio copying Thrive Capital Management, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +14.3% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +20.0% against +20.1%. Over 5 years: +5.9% a year against +11.2%.

When is Thrive Capital Management, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Thrive Capital Management, LLC's filing for the quarter ending Dec 31, 2026 is due by Feb 14, 2027; this page updates the day after it is published.

How much money does Thrive Capital Management, LLC manage?

Thrive Capital Management, LLC reported $50.5B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $557.4M.